Post-discharge Cessation for Smoking Patients

NCT05430789 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 770

Last updated 2022-07-19

No results posted yet for this study

Summary

This study aims to enhance the general 5As brief advice model with interactive mobile phone-based intervention and active referral to community smoking cessation services for smoking patients discharged from hospitals.

Conditions

  • Smoking Cessation
  • Post-discharge
  • Mobile Health

Interventions

BEHAVIORAL

5As brief advice

Participants will receive brief face-to-face advice following a 5As model at baseline: 1. Ask: Smoking patients will be asked about their smoking status. 2. Advise: Smoking patients will be advised to quit in a clear and personalised manner, with a focus on smoking-related diseases. 3. Assess: Smoking patients will be assessed for their readiness to quit by assessing their self-efficacy and perceived importance. 4. Assist: Those who are ready to quit will be assisted in setting a quit plan. 5. Arrange: Refer to smoking cessation services.

BEHAVIORAL

Self-help e-booklet

A 12-page generic self-help smoking cessation e-booklet via IM apps, including: 1. Highlights of the absolute risk of death due to smoking; 2. Smoking and diseases management; 3. Ten horrible pictorial warnings of health consequences of smoking and second-hand smoking; 4. Benefits of quitting; 5. Methods to quit and handle. withdrawal symptoms.

BEHAVIORAL

Nurse-led mHealth intervention

Participants will receive real-time mHealth behaviour and psychosocial support for 12 weeks after baseline through IM apps. mHealth intervention consists of two main parts: regular instant messaging on smoking cessation and personalized real-time mHealth chatting on smoking and disease (including active referral to smoking cessation service)

BEHAVIORAL

Regular intervention

Participants will receive text messages using IM app with content on general health and reminding the importance of participating in the follow-up surveys and biochemical validation for quitting.

Sponsors & Collaborators

  • Queen Mary Hospital, Hong Kong

    collaborator OTHER
  • Princess Margaret Hospital, Hong Kong

    collaborator OTHER_GOV
  • Queen Elizabeth Hospital, Hong Kong

    collaborator OTHER
  • Kwong Wah Hospital

    collaborator OTHER
  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Man Ping Wang, PhD · The University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-24
Primary Completion
2024-05-31
Completion
2024-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05430789 on ClinicalTrials.gov